Osteochondral Tissue Engineering is a cutting-edge field focused on developing strategies to repair and regenerate both bone (osteo-) and cartilage (-chondral) tissues within joints. This multidisciplinary approach combines principles from engineering, biology, and materials science to address the complex structure and functionality of the osteochondral unit. The goal is to create biomimetic constructs that can effectively replace damaged or degenerated joint tissues, providing a promising alternative to conventional treatments. Researchers in osteochondral tissue engineering design scaffolds that mimic the native tissue architecture, supporting the growth and differentiation of osteogenic and chondrogenic cells. These scaffolds often incorporate biocompatible materials, such as hydrogels or polymers, with mechanical properties resembling those of natural cartilage and bone. Additionally, the inclusion of bioactive factors, such as growth factors and signaling molecules, helps guide cell behavior and tissue regeneration. Cell sources play a crucial role in osteochondral tissue engineering, with mesenchymal stem cells being a common choice due to their ability to differentiate into both bone-forming and cartilage-forming cells. Advances in 3D printing and bioprinting technologies enable precise control over scaffold architecture, allowing for the creation of intricate structures that support the development of functional osteochondral tissues. Osteochondral tissue engineering holds significant promise for treating conditions like osteoarthritis, osteochondral defects, and joint injuries. Successful strategies aim to restore the biomechanical properties of the joint, alleviate pain, and improve overall joint function. As research in this field progresses, the hope is to provide patients with more effective and durable solutions for joint repair and regeneration, ultimately enhancing the quality of life for individuals with joint-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy